Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 4/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | NOS3 | P29474 | 3/20 | 0.31 |
| ▸ | NOS2 | P35228 | 3/20 | 0.31 |
| ▸ | NOS1 | P29475 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10084780 | 0.80 | RET (0.33) | NOS3 | |
| SCHEMBL1781575 | 0.73 | ALDH1A1 (0.39) | — | |
| SCHEMBL1779983 | 0.72 | CYP1A2 (0.43) | NOS3NOS2 | |
| SCHEMBL11090288 | 0.70 | BACE1 (0.36) | BACE1NOS3NOS2NOS1 | |
| SCHEMBL2419200 | 0.67 | NOS2 (0.42) | BACE1NOS3NOS2NOS1 | |
| SCHEMBL7770169 | 0.60 | HDAC4 (0.34) | BACE1 | |
| SCHEMBL12604643 | 0.60 | SMARCA2 (0.31) | — | |
| SCHEMBL1033624 | 0.60 | NOTUM (0.34) | — | |
| SCHEMBL577130 | 0.58 | CA12 (0.40) | — | |
| SCHEMBL25630378 | 0.57 | CA2 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8173641-B2 | 4-amino-1,2,3-benzoxathiazine-derivatives as pesticides | BAYER CROPSCIENCE AG (DE) | 2012-05-08 | — | — | US | disclosed |
| US-8173641-B2 | 4-amino-1,2,3-benzoxathiazine-derivatives as pesticides | BAYER CROPSCIENCE AG (DE) | 2012-05-08 | — | — | US | disclosed |
| US-8173641-B2 | 4-amino-1,2,3-benzoxathiazine-derivatives as pesticides | BAYER CROPSCIENCE AG (DE) | 2012-05-08 | — | — | US | disclosed |
| US-20110118240-A2 | 4-Amino-1,2,3-Benzoxathiazine-Derivatives as Pesticides | BAYER CROPSCIENCE AG (DE) | 2011-05-19 | — | — | US | disclosed |
| US-20110118240-A2 | 4-Amino-1,2,3-Benzoxathiazine-Derivatives as Pesticides | BAYER CROPSCIENCE AG (DE) | 2011-05-19 | — | — | US | disclosed |
| US-20110118240-A2 | 4-Amino-1,2,3-Benzoxathiazine-Derivatives as Pesticides | BAYER CROPSCIENCE AG (DE) | 2011-05-19 | — | — | US | disclosed |
| US-20100267703-A1 | 4-Amino-1,2,3-benzoxathiazine-Derivatives as Pesticides | BAYER CROPSCIENCE AG (DE) | 2010-10-21 | — | — | US | disclosed |
| US-20100267703-A1 | 4-Amino-1,2,3-benzoxathiazine-Derivatives as Pesticides | BAYER CROPSCIENCE AG (DE) | 2010-10-21 | — | — | US | disclosed |
| US-20100267703-A1 | 4-Amino-1,2,3-benzoxathiazine-Derivatives as Pesticides | BAYER CROPSCIENCE AG (DE) | 2010-10-21 | — | — | US | disclosed |
| WO-2010072310-A1 | 4-AMINO-1,2,3- BENZOXATHIAZINE DERIVATIVES AS PESTICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2010-07-01 | — | — | WO | disclosed |
| EP-2196461-A1 | 4-Amino-1,2,3-benzoxathiazine-derivatives as pesticides | Bayer CropScience AG (DE) | 2010-06-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267703-A1 | 4-Amino-1,2,3-benzoxathiazine-Derivatives as Pesticides | P2RX5, SLC1A5, P2RX4 | BACE1 2802/4885KCNH2 881/4885NOS3 2434/4885 |
| US-20110118240-A2 | 4-Amino-1,2,3-Benzoxathiazine-Derivatives as Pesticides | P2RX5, P2RX4, SLC1A5 | BACE1 2103/4885KCNH2 586/4885NOS3 2253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.